Detalhe da pesquisa
1.
The GABAergic system in Alzheimer's disease: a systematic review with meta-analysis.
Mol Psychiatry
; 2023 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37419974
2.
Genetic risk for attention-deficit/hyperactivity disorder predicts cognitive decline and development of Alzheimer's disease pathophysiology in cognitively unimpaired older adults.
Mol Psychiatry
; 28(3): 1248-1255, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36476732
3.
Association of plasma biomarkers of Alzheimer's disease and related disorders with cognition and cognitive decline: The MYHAT population-based study.
Alzheimers Dement
; 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38753951
4.
A novel ultrasensitive assay for plasma p-tau217: Performance in individuals with subjective cognitive decline and early Alzheimer's disease.
Alzheimers Dement
; 20(2): 1239-1249, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37975513
5.
Hippocampal GFAP-positive astrocyte responses to amyloid and tau pathologies.
Brain Behav Immun
; 110: 175-184, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36878332
6.
Astrocyte biomarker signatures of amyloid-ß and tau pathologies in Alzheimer's disease.
Mol Psychiatry
; 27(11): 4781-4789, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35948658
7.
Plasma biomarkers identify older adults at risk of Alzheimer's disease and related dementias in a real-world population-based cohort.
Alzheimers Dement
; 19(10): 4507-4519, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36876954
8.
Blood-brain barrier integrity impacts the use of plasma amyloid-ß as a proxy of brain amyloid-ß pathology.
Alzheimers Dement
; 19(9): 3815-3825, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36919582
9.
Plasma p-tau231 and p-tau217 inform on tau tangles aggregation in cognitively impaired individuals.
Alzheimers Dement
; 19(10): 4463-4474, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37534889
10.
Sex differences in Alzheimer's disease blood biomarkers in a Caribbean population of African ancestry: The Tobago Health Study.
Alzheimers Dement (N Y)
; 10(2): e12460, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38617114
11.
Predicting functional decline in aging and Alzheimer's disease with PET-based Braak staging.
Brain Commun
; 6(2): fcae043, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38482373
12.
Vascular risk burden is a key player in the early progression of Alzheimer's disease.
Neurobiol Aging
; 136: 88-98, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38335912
13.
Endocannabinoid System Biomarkers in Alzheimer's Disease.
Cannabis Cannabinoid Res
; 8(1): 77-91, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36394442
14.
Discriminative accuracy of the A/T/N scheme to identify cognitive impairment due to Alzheimer's disease.
Alzheimers Dement (Amst)
; 15(1): e12390, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36733847
15.
Potential Utility of Plasma P-Tau and Neurofilament Light Chain as Surrogate Biomarkers for Preventive Clinical Trials.
Neurology
; 101(1): 38-45, 2023 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36878697
16.
A novel ultrasensitive assay for plasma p-tau217: performance in individuals with subjective cognitive decline and early Alzheimer's disease.
medRxiv
; 2023 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37873312
17.
Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography.
JAMA Neurol
; 80(2): 188-199, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36508198
18.
The Association of Age-Related and Off-Target Retention with Longitudinal Quantification of [18F]MK6240 Tau PET in Target Regions.
J Nucl Med
; 64(3): 452-459, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36396455
19.
Astrocyte reactivity influences amyloid-ß effects on tau pathology in preclinical Alzheimer's disease.
Nat Med
; 29(7): 1775-1781, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37248300
20.
APOEε4 associates with microglial activation independently of Aß plaques and tau tangles.
Sci Adv
; 9(14): eade1474, 2023 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37018391